Stay updated on Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3 on the page, reflecting a newer build or template version. No study data, eligibility criteria, or results content were altered; the change appears limited to the page's version tag.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.5.2 is now displayed, replacing the previous Revision: v3.5.0. This appears to be a minor version update that does not affect study details or user interactions.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision label updated to v3.5.0 and the previous v3.4.3 label removed. No changes to study details, layout, or navigation are observed.SummaryDifference0.1%

- Check63 days agoChange DetectedThe site revision label in the footer was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check92 days agoChange DetectedFooter now shows Revision: v3.4.2, replacing the previous government-activity notices tied to older revisions. This is a minor maintenance update unrelated to study content or user actions.SummaryDifference0.4%

- Check99 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH operating status. Updated the site to Revision 3.4.1, replacing Revision 3.4.0.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial page.